08.04.2020 06:59:59
|
Press Release: Addex Reports 2019 Full Year -2-
Certain statements made in this announcement are forward-looking
statements including with respect to the creation of a trading market
for ADSs representing the Company's shares in the United States. These
forward-looking statements are not historical facts but rather are based
on the Company's current expectations, estimates, and projections about
its industry; its beliefs; and assumptions. Words such as 'anticipates,'
'expects,' 'intends,' 'plans,' 'believes,' 'seeks,' 'estimates,' and
similar expressions are intended to identify forward-looking statements.
These statements are not guarantees of future performance and are
subject to known and unknown risks, uncertainties, and other factors,
some of which are beyond the Company's control, are difficult to predict,
and could cause actual results to differ materially from those expressed
or forecasted in the forward-looking statements. The Company cautions
securityholders and prospective securityholders not to place undue
reliance on these forward-looking statements, which reflect the view of
the Company only as of the date of this announcement. The
forward-looking statements made in this announcement relate only to
events as of the date on which the statements are made. The Company will
not undertake any obligation to release publicly any revisions or
updates to these forward-looking statements to reflect events,
circumstances, or unanticipated events occurring after the date of this
announcement except as required by law or by any appropriate regulatory
authority.
(END) Dow Jones Newswires
April 08, 2020 01:00 ET (05:00 GMT)

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Addex Therapeutics Ltd (spons. ADRs)mehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Addex Therapeutics Ltd (spons. ADRs)mehr Analysen
Aktien in diesem Artikel
Addex Therapeutics Ltd. | 1,37 | -17,96% |
|